Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,605 | 87 | 91.9% |
| Education | $140.99 | 2 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $666.57 | 39 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $379.13 | 15 | $0 (2023) |
| Supernus Pharmaceuticals, Inc. | $182.86 | 11 | $0 (2024) |
| ABBVIE INC. | $109.33 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $100.93 | 4 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $99.46 | 5 | $0 (2024) |
| Vanda Pharmaceuticals Inc. | $84.16 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $36.88 | 2 | $0 (2024) |
| Alkermes, Inc. | $24.69 | 1 | $0 (2023) |
| Lundbeck LLC | $15.99 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $430.80 | 22 | Teva Pharmaceuticals USA, Inc. ($187.88) |
| 2023 | $419.14 | 24 | Teva Pharmaceuticals USA, Inc. ($150.13) |
| 2022 | $727.59 | 32 | Teva Pharmaceuticals USA, Inc. ($284.81) |
| 2021 | $152.66 | 10 | Neurocrine Biosciences, Inc. ($59.02) |
| 2018 | $15.89 | 1 | Novo Nordisk Inc ($15.89) |
All Payment Transactions
89 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $20.51 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/03/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $12.28 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/13/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.43 | General |
| Category: Central Nervous System | ||||||
| 11/12/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Central Nervous System | ||||||
| 11/07/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $16.37 | General |
| Category: Psychiatry/Psychology | ||||||
| 11/01/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/17/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $9.96 | General |
| Category: Neurology | ||||||
| 10/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: PSYCHIATRY | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Central Nervous System | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $0.26 | General |
| Category: Central Nervous System | ||||||
| 08/13/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 08/07/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 07/19/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $79.50 | General |
| 06/18/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.88 | General |
| Category: Central Nervous System | ||||||
| 06/06/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Neuroscience | ||||||
| 05/16/2024 | Indivior Inc. | PERSERIS (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: BH | ||||||
| 04/19/2024 | Janssen Pharmaceuticals, Inc | INVEGA TRINZA (Drug), INVEGA SUSTENNA | Food and Beverage | In-kind items and services | $37.32 | General |
| Category: Neuroscience | ||||||
| 04/16/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Neurology | ||||||
| 03/07/2024 | Noven Therapeutics, LLC | Secuado (Drug), Xelstrym | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: CNS Psychiatry | ||||||
| 02/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: Neurology | ||||||
| 11/28/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Neurology | ||||||
| 11/16/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Neuroscience | ||||||
| 10/23/2023 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Neuropsychiatry | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 131 | 259 | $55,697 | $17,545 |
| 2022 | 5 | 199 | 366 | $46,851 | $23,606 |
| 2021 | 3 | 132 | 179 | $15,065 | $9,896 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 34 | 69 | $9,556 | $5,315 | 55.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 33 | 77 | $8,109 | $4,255 | 52.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 27 | 58 | $17,751 | $3,806 | 21.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 18 | 31 | $15,560 | $3,251 | 20.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 19 | 24 | $4,721 | $917.89 | 19.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 74 | 163 | $21,870 | $13,074 | 59.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 80 | $7,600 | $4,897 | 64.4% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 18 | 18 | $4,053 | $2,564 | 63.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 14 | 14 | $7,027 | $1,500 | 21.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 20 | $6,121 | $1,449 | 23.7% |
| Q3014 | Telehealth originating site facility fee | Office | 2022 | 30 | 71 | $180.34 | $122.43 | 67.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 90 | $11,820 | $7,755 | 65.6% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2021 | 14 | 14 | $3,054 | $1,993 | 65.3% |
| Q3014 | Telehealth originating site facility fee | Office | 2021 | 52 | 75 | $190.50 | $148.19 | 77.8% |
About Dr. Kenneth Stephens, M.D
Dr. Kenneth Stephens, M.D is a Psychiatry healthcare provider based in Monticello, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2007. The National Provider Identifier (NPI) number assigned to this provider is 1942411483.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kenneth Stephens, M.D has received a total of $1,746 in payments from pharmaceutical and medical device companies, with $430.80 received in 2024. These payments were reported across 89 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,605).
As a Medicare-enrolled provider, Stephens has provided services to 462 Medicare beneficiaries, totaling 804 services with total Medicare billing of $51,047. Data is available for 3 years (2021–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Location Monticello, AR
- Active Since 05/25/2007
- Last Updated 10/03/2024
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1942411483
Products in Payments
- INGREZZA (Drug) $379.13
- AUSTEDO (Drug) $307.70
- Austedo XR (Drug) $133.26
- QELBREE (Drug) $130.88
- VRAYLAR (Drug) $109.33
- UZEDY (Drug) $84.62
- HETLIOZ (Drug) $84.16
- REXULTI (Drug) $79.03
- Qelbree (Drug) $51.98
- INVEGA SUSTENNA (Drug) $47.94
- INVEGA TRINZA (Drug) $37.32
- COBENFY (Drug) $36.88
- ABILIFY MAINTENA (Drug) $36.42
- ARISTADA (Drug) $24.69
- Victoza (Drug) $15.89
- SPRAVATO (Drug) $15.67
- PERSERIS (Drug) $15.62
- Secuado (Drug) $14.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Monticello
Mr. Peter Panzarino, Md, MD
Psychiatry — Payments: $12,050
Dr. Geetha Aakalu, M.d, M.D
Psychiatry — Payments: $141.67
Khin Myo, Md, MD
Psychiatry — Payments: $64.82
Pe Win, Md, MD
Psychiatry
Dr. Ronald Serocki, M.d, M.D
Psychiatry
Dr. Moolamannil Joseph, Md, MD
Psychiatry